MedPath

Hereditary Thrombophilia in the Pathogenesis of Myocardial Infarction and Coronary Artery Bypass Graft Occlusion: New Role for an Old Actress.

Completed
Conditions
Heart attack
10011082
acute coronary syndrome
Registration Number
NL-OMON42575
Lead Sponsor
Sint Antonius Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
887
Inclusion Criteria

Patients with unstable angina or non-ST-segment elevation myocardial infarction.
Age above 18 years;ST-segment elevation myocardial infarction (STEMI) patients for comparison will be selected from an existing dataset of ongoing trial (i.e., POPular Genetics).

Exclusion Criteria

Patients who are unable or unwilling to give informed consent (e.g., due to metal illnesses or inability to understand Dutch language).
Individuals younger than 18 years of age.
Patients with previous ST-segment elevation myocardial infarction (STEMI)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Prevalence of factor V Leiden or Prothrombin G20210A in STEMI as compared to<br /><br>NSTEMI/uAP patients.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Hemorrhagic complications during the index hospitalization in patients with<br /><br>versus without factor V Leiden or prothrombin G20210A mutations.</p><br>
© Copyright 2025. All Rights Reserved by MedPath